Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20028633HPVENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS20027872HPVENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS20070100HPVENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS20027871HPVENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS20069680HPVENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS44022884HTLV-1ENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS44022885HTLV-1ENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS44020006HTLV-1ENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS44049194HTLV-1ENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS44045896HTLV-1ENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TCGA Plot Options
Drug Information
GeneLYN
DrugBank IDDB09079
Drug NameNintedanib
Target IDBE0004315
UniProt IDP07948
Regulation Typeinhibitor
PubMed IDs18559524; 31016670
CitationsHilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U, Garin-Chesa P, Bader G, Zoephel A, Quant J, Heckel A, Rettig WJ: BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res. 2008 Jun 15;68(12):4774-82. doi: 10.1158/0008-5472.CAN-07-6307.@@Wind S, Schmid U, Freiwald M, Marzin K, Lotz R, Ebner T, Stopfer P, Dallinger C: Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib. Clin Pharmacokinet. 2019 Sep;58(9):1131-1147. doi: 10.1007/s40262-019-00766-0.
GroupsApproved
Direct ClassificationIndolecarboxylic acids
SMILESCOC(=O)C1=CC=C2C(NC(=O)C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Pathways
PharmGKB
ChEMBLCHEMBL502835